Contract development and manufacturing organisation (CDMO), Hovione, has announced that its MG2 Tekna Precision Capsule filling unit is now online in its Portugal facility, complementing its offering in encapsulation for inhalation products.
Portugal flag
This unit, which complements the existing MG2 Flexalab and Mettler-Toledo Quantos encapsulation units, allows capsule filling for Phase I and II clinical trials. At the same time, the company has installed capacity in particle engineering suitable for inhalation — a multiple scale spray drying unit for highly potent compounds and a wet polishing suite as well as strengthening its analytical characterisation toolbox.
“We are excited to announce this new integrated offering, all at the same site where our scientists work together in the interface between particle engineering and final drug product for the benefit of an optimal product performance. This will allow us to support our customer’s inhalation projects at all scales and contribute to accelerate drug development and manufacturing timelines,” said Filipe Gaspar, vice president R&D.
“These investments are driven by significant client demand, since the market is looking for integrated inhalation product development solutions that reduce program risk and complexity. Hovione has all the ingredients for an outstanding partnership starting from clinical programs and into commercial supply,” added Frédéric Kahn, vice president Marketing and Sales.